Fifteen years of bone marrow mononuclear cell therapy in acute myocardial infarction
Open Access
- 1 January 2017
- journal article
- review article
- Published by Baishideng Publishing Group Inc. in World Journal of Stem Cells
- Vol. 9 (4) , 68-76
Abstract
In spite of modern treatment, acute myocardial infarction (AMI) still carries significant morbidity and mortality worldwide. Even though standard of care therapy improves symptoms and also long-term prognosis of patients with AMI, it does not solve the critical issue, specifically the permanent damage of cardiomyocytes. As a result, a complex process occurs, namely cardiac remodeling, which leads to alterations in cardiac size, shape and function. This is what has driven the quest for unconventional therapeutic strategies aiming to regenerate the injured cardiac and vascular tissue. One of the latest breakthroughs in this regard is stem cell (SC) therapy. Based on favorable data obtained in experimental studies, therapeutic effectiveness of this innovative therapy has been investigated in clinical settings. Of various cell types used in the clinic, autologous bone marrow derived SCs were the first used to treat an AMI patient, 15 years ago. Since then, we have witnessed an increasing body of data as regards this cutting-edge therapy. Although feasibility and safety of SC transplant have been clearly proved, it’s efficacy is still under dispute. Conducted studies and meta-analysis reported conflicting results, but there is hope for conclusive answer to be provided by the largest ongoing trial designed to demonstrate whether this treatment saves lives. In the meantime, strategies to enhance the SCs regenerative potential have been applied and/or suggested, position papers and recommendations have been published. But what have we learned so far and how can we properly use the knowledge gained? This review will analytically discuss each of the above topics, summarizing the current state of knowledge in the field.Keywords
This publication has 71 references indexed in Scilit:
- Meta-Analyses of Human Cell-Based Cardiac Regeneration TherapiesCirculation Research, 2016
- Short-Term Effect of Autologous Bone Marrow Stem Cells to Treat Acute Myocardial Infarction: A Meta-Analysis of Randomized Controlled Clinical TrialsJournal of Cardiovascular Translational Research, 2015
- A critical challenge: Dosage-related efficacy and acute complication intracoronary injection of autologous bone marrow mesenchymal stem cells in acute myocardial infarctionInternational Journal of Cardiology, 2013
- Intracoronary Injection of Bone Marrow–Derived Mononuclear Cells Early or Late After Acute Myocardial InfarctionCirculation, 2013
- Intracoronary stem cell injection improves left ventricular remodeling after acute myocardial infarction: An updated meta-analysis of randomized trialsInternational Journal of Cardiology, 2011
- Development of a Network to Test Strategies in Cardiovascular Cell Delivery: The NHLBI-sponsored Cardiovascular Cell Therapy Research Network (CCTRN)Journal of Cardiovascular Translational Research, 2009
- Intracoronary bone marrow cell transfer after myocardial infarction: 5-year follow-up from the randomized-controlled BOOST trialEuropean Heart Journal, 2009
- Autologous bone marrow stem cells to treat acute myocardial infarction: a systematic reviewEuropean Heart Journal, 2008
- Intracoronary Bone Marrow–Derived Progenitor Cells in Acute Myocardial InfarctionNew England Journal of Medicine, 2006
- Intracoronary Bone Marrow Cell Transfer After Myocardial InfarctionCirculation, 2006